Casdin Capital, LLC Codexis, Inc. Transaction History
Casdin Capital, LLC
- $1.29 Billion
- Q3 2024
A detailed history of Casdin Capital, LLC transactions in Codexis, Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 8,100,000 shares of CDXS stock, worth $32.7 Million. This represents 1.94% of its overall portfolio holdings.
Number of Shares
8,100,000
Previous 2,000,000
305.0%
Holding current value
$32.7 Million
Previous $6.2 Million
302.39%
% of portfolio
1.94%
Previous 0.53%
Shares
14 transactions
Others Institutions Holding CDXS
# of Institutions
127Shares Held
48.1MCall Options Held
33.7KPut Options Held
20.2K-
Opaleye Management Inc. Boston, MA8.77MShares$35.4 Million4.93% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$27.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.15MShares$16.8 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.97MShares$12 Million0.54% of portfolio
-
Telemark Asset Management, LLC Boston, MA2.7MShares$10.9 Million0.89% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $265M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...